SYK stock icon

Stryker
SYK

$334.64
0.36%

Market Cap: 127B

 

About: Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.

Employees: 52,000

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 24 analysts
0
News positive %
of 7 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

82% more first-time investments, than exits

New positions opened: 208 | Existing positions closed: 114

73% more call options, than puts

Call options by funds: $542M | Put options by funds: $314M

18% more funds holding in top 10

Funds holding in top 10: 67 [Q4 2023] → 79 (+12) [Q1 2024]

17% more capital invested

Capital invested by funds: $87.9B [Q4 2023] → $103B (+$15.2B) [Q1 2024]

5% more funds holding

Funds holding: 1,831 [Q4 2023] → 1,925 (+94) [Q1 2024]

3% more repeat investments, than reductions

Existing positions increased: 713 | Existing positions reduced: 695

1.08% less ownership

Funds ownership: 77.15% [Q4 2023] → 76.07% (-1.08%) [Q1 2024]

Research analyst outlook

24 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$345
3%
upside
Avg. target
$372
11%
upside
High target
$406
21%
upside

24 analyst ratings

20 positive
83%
neutral
17%
negative
0%
Morgan Stanley
Drew Ranieri
5%upside
$350
Equal-Weight
Maintained
15 Jul 2024
BTIG
Ryan Zimmerman
11%upside
$372
Buy
Maintained
15 Jul 2024
Evercore ISI Group
Vijay Kumar
9%upside
$365
Outperform
Maintained
2 Jul 2024
Goldman Sachs
David Roman
11%upside
$372
Neutral
Initiated
30 May 2024
Needham
Mike Matson
17%upside
$392
Buy
Upgraded
22 May 2024

Financial journalist opinion

Based on 7 articles about SYK published over the past 30 days